Affiliation:
1. Cardiovascular Department, Servicio de Cardiología, Hospital Universitario Virgen Macarena
2. Departamento de Medicina Preventiva y Salud Pública, Universidad de Sevilla, Sevilla, Spain
Abstract
Aim
The aim of this study was to determine the best clinical predictors of acute heart failure needing mechanical ventilation (MV) in the first 48 h of evolution of patients admitted because of acute coronary syndrome (ACS).
Methods
We analyzed a cohort of patients admitted for ACS between February 2017 and February 2018. A pulmonary ultrasound was performed on admission and was considered positive (PE+) when there were three or more B-lines in two quadrants or more of each hemithorax. It was compared with N-terminal pro–B-type natriuretic peptide (NT-proBNP), peak troponin T-us value GRACE (Global Registry of Acute Coronary Events), CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology and American Heart Association guidelines – Bleeding Score), CACS (Canada Acute Coronary Syndrome risk score), and HAMIOT (Heart Failure after Acute Myocardial Infarction with Optimal Treatment score) scores, shock index, ejection fraction, chest X-ray, and Killip class at admission as predictors of MV in the first 48 h of admission.
Results
A total of 119 patients were included: 54.6% with ST elevation and 45.4% without ST elevation. Twelve patients (10.1%) required MV in the first 48 h of evolution. The sensitivity of PE+ was 100% (73.5–100%), specificity 91.6% (84.6–96.1%), and area under the curve was 0.96 (0.93–0.96). The sensitivity of an NT-proBNP value more than 3647 was 88.9% (51.9–99.7%), specificity 92.1% (84.5–96.8%), and area under the curve was 0.905 (0.793–1). The κ statistic between both predictors was 0.579. All the other scores were significantly worse than PE + .
Conclusion
Lung ultrasound and a high NT-proBNP (3647 ng/L in our series) on admission are the best predictors of acute heart failure needing MV in the first 48 h of ACS. The agreement between both tests was only moderate.
Publisher
Ovid Technologies (Wolters Kluwer Health)